Tremfya tops Cosentyx in late-stage study
admin 12th August 2019 Uncategorised 0The study is the first to compare Tremfya and the IL-17 inhibitor, Cosentyx.
More: Tremfya tops Cosentyx in late-stage study
Source: News
The study is the first to compare Tremfya and the IL-17 inhibitor, Cosentyx.
More: Tremfya tops Cosentyx in late-stage study
Source: News
© 1994 - 2025 B.M. Pharmaceuticals